Literature DB >> 23737686

Examining the use of salpingectomy with hysterectomy in Canada.

C Sandoval1, M Fung-Kee-Fung, B Gilks, K J Murphy, R Rahal, H Bryant.   

Abstract

Year:  2013        PMID: 23737686      PMCID: PMC3671023          DOI: 10.3747/co.20.1560

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  6 in total

Review 1.  The role of the fallopian tube in ovarian cancer.

Authors:  Alicia A Tone; Shannon Salvador; Sarah J Finlayson; Anna V Tinker; Janice S Kwon; Cheng-Han Lee; Trevor Cohen; Tom Ehlen; Marette Lee; Mark S Carey; Mark Heywood; Judith Pike; Paul J Hoskins; Gavin C Stuart; Kenneth D Swenerton; David G Huntsman; C Blake Gilks; Dianne M Miller; Jessica N McAlpine
Journal:  Clin Adv Hematol Oncol       Date:  2012-05

2.  Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

Authors:  Janice S Kwon; Anna Tinker; Gary Pansegrau; Jessica McAlpine; Melissa Housty; Mary McCullum; C Blake Gilks
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

3.  Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

Authors:  Mark H Greene; Phuong L Mai; Peter E Schwartz
Journal:  Am J Obstet Gynecol       Date:  2010-07-08       Impact factor: 8.661

Review 4.  The post-reproductive Fallopian tube: better removed?

Authors:  J Dietl; J Wischhusen; S F M Häusler
Journal:  Hum Reprod       Date:  2011-08-16       Impact factor: 6.918

Review 5.  The fallopian tube: primary site of most pelvic high-grade serous carcinomas.

Authors:  Shannon Salvador; Blake Gilks; Martin Köbel; David Huntsman; Barry Rosen; Dianne Miller
Journal:  Int J Gynecol Cancer       Date:  2009-01       Impact factor: 3.437

6.  Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.

Authors:  Timothy R Rebbeck; Noah D Kauff; Susan M Domchek
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

  6 in total
  5 in total

1.  Preventing ovarian cancer by salpingectomy.

Authors:  W D Foulkes
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

2.  Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma.

Authors:  Collette R Lessard-Anderson; Kathryn S Handlogten; Rochelle J Molitor; Sean C Dowdy; William A Cliby; Amy L Weaver; Jennifer St Sauver; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2014-10-12       Impact factor: 5.482

3.  Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.

Authors:  Gillian E Hanley; Jin Niu; Jihee Han; Sharon Fung; Heather Bryant; Janice S Kwon; David G Huntsman; Sarah J Finlayson; Jessica N McAlpine; Dianne Miller; Craig C Earle
Journal:  CMAJ Open       Date:  2022-05-31

Review 4.  Opportunistic salpingectomy for ovarian cancer prevention.

Authors:  Gillian E Hanley; Jessica N McAlpine; Janice S Kwon; Gillian Mitchell
Journal:  Gynecol Oncol Res Pract       Date:  2015-09-17

5.  Evaluation of ovarian function after hysterectomy with or without salpingectomy: A feasible study.

Authors:  Fariba Behnamfar; Hajar Jabbari
Journal:  J Res Med Sci       Date:  2017-05-30       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.